Literature DB >> 23223637

Detection and grading of coronary allograft vasculopathy in children with contrast-enhanced magnetic resonance imaging of the coronary vessel wall.

Tarique Hussain1, Matthew Fenton, Sarah A Peel, Andrea J Wiethoff, Andrew Taylor, Vivek Muthurangu, Reza Razavi, Rene M Botnar, Michael Burch, Gerald F Greil.   

Abstract

BACKGROUND: Coronary allograft vasculopathy is the leading cause of late death after heart transplantation in children. It is poorly detected by conventional angiography. Intravascular ultrasound is invasive and costly. This study shows that magnetic resonance imaging (MRI) late gadolinium enhancement (LGE) of the coronary vessel wall can detect and grade coronary allograft vasculopathy. METHODS AND
RESULTS: Twenty-four children (10 male; age range, 9-17 years) underwent coronary angiography, intravascular ultrasound, and MRI. Maximal intimal thickness and mean intimal index were recorded. MRI included coronary magnetic resonance angiogram and LGE vessel wall imaging with 1.5 T (n=12) and 3.0 T (n=12). Ten healthy control subjects also underwent LGE MRI. Mean time posttransplantation was 5.5 years (range, 0.25-14 years). Seven patients had Stanford grade IV coronary allograft vasculopathy on intravascular ultrasound, 3 of whom had angiographic disease. Maximal intimal thickness and mean intimal index were 0.73±0.50 mm and 20.9±10.6%, respectively. On MRI, mean diameter of enhancement of vessel wall was 6.57±4.91 mm, and mean enhancement index (indexed to vessel lumen size) was 1.10±1.72. The control group showed little or no LGE. Correlation of LGE with maximal intimal thickness using the Pearson coefficient was 0.80 (P<0.001) and with mean intimal index was 0.92 (P<0.001). An MRI diameter >7.5 mm gave 86% sensitivity and 93% specificity.
CONCLUSIONS: LGE scores correlate well with traditional intravascular ultrasound measures. These promising early results encourage larger-scale clinical studies to investigate whether LGE MRI will allow closer follow-up and better prevention of coronary allograft vasculopathy in children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223637     DOI: 10.1161/CIRCIMAGING.112.975797

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  10 in total

Review 1.  Multi-modal imaging of the pediatric heart transplant recipient.

Authors:  Jonathan H Soslow; Margaret M Samyn
Journal:  Transl Pediatr       Date:  2019-10

Review 2.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 3.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

4.  Dual-Axis Rotational Angiography is Safe and Feasible to Detect Coronary Allograft Vasculopathy in Pediatric Heart Transplant Patients: A Single-Center Experience.

Authors:  Rodrigo Rios; Rohit S Loomba; Susan R Foerster; Andrew N Pelech; Todd M Gudausky
Journal:  Pediatr Cardiol       Date:  2016-02-04       Impact factor: 1.655

Review 5.  The Value of Cardiovascular Magnetic Resonance in Heart Transplant Patients.

Authors:  Anna B Reid; Nick Waldron; Matthias Schmitt; Christopher A Miller
Journal:  Curr Cardiol Rep       Date:  2015-07       Impact factor: 2.931

Review 6.  Coronary artery imaging in children.

Authors:  Hyun Woo Goo
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500

7.  Influence of acquired obesity on coronary vessel wall late gadolinium enhancement in discordant monozygote twins.

Authors:  Marcus R Makowski; Christian H P Jansen; Ullrich Ebersberger; Tobias Schaeffter; Reza Razavi; Massimo Mangino; Tim D Spector; Rene M Botnar; Gerald F Greil
Journal:  Eur Radiol       Date:  2016-10-14       Impact factor: 5.315

Review 8.  SCMR expert consensus statement for cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease.

Authors:  Adam L Dorfman; Tal Geva; Margaret M Samyn; Gerald Greil; Rajesh Krishnamurthy; Daniel Messroghli; Pierluigi Festa; Aurelio Secinaro; Brian Soriano; Andrew Taylor; Michael D Taylor; René M Botnar; Wyman W Lai
Journal:  J Cardiovasc Magn Reson       Date:  2022-07-21       Impact factor: 6.903

9.  Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients.

Authors:  Niharika Varma; Rocio Hinojar; David D'Cruz; Eduardo Arroyo Ucar; Andreas Indermuehle; Sarah Peel; Gerald Greil; Nicholas Gaddum; Phil Chowienczyk; Eike Nagel; Rene M Botnar; Valentina O Puntmann
Journal:  JACC Cardiovasc Imaging       Date:  2014-07-16

10.  Contrast-enhanced magnetic resonance imaging for the detection of ruptured coronary plaques in patients with acute myocardial infarction.

Authors:  Christian H P Jansen; Divaka Perera; Andrea J Wiethoff; Alkystis Phinikaridou; Reza M Razavi; Aldo Rinaldi; Mike S Marber; Gerald F Greil; Eike Nagel; David Maintz; Simon Redwood; Rene M Botnar; Marcus R Makowski
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.